FDA全球物质注册数据库(FDA Global Substance Registration System)
物质名称TOVESANGENE PARVEC
异名/同义词JAG-201
RECOMBINANT NON-REPLICATING ADENO-ASSOCIATED VIRUS SEROTYPE 9 (RAAV9) VECTOR ENCODING A MINIATURISED VERSION OF HUMAN SHANK3 (SH3 AND MULTIPLE ANKYRIN REPEAT DOMAINS 3, PROLINE-RICH SYNAPSE-ASSOCIATED PROTEIN 2 (PROSAP2); CORRESPONDING TO AMINO ACIDS 537-782, 1347-1806 OF THE FULL-LENGTH SHANK3 PROTEIN, M1>ADDED) PRECEDED BY A KOZAK SEQUENCE WITH EXPRESSION UNDER CONTROL OF THE HUMAN SYNAPSIN I PROMOTER, A WOODCHUCK HEPATITIS VIRUS POST-TRANSCRIPTIONAL REGULATORY ELEMENT (WPRE) AND A HUMAN GROWTH HORMONE (HGH) POLYADENYLATION SIGNAL; FLANKED BY AAV2 INVERTED TERMINAL REPEATS (ITRS)
TOVESANGENE PARVEC [INN]
TOVESANGENE PARVEC
CAS登记号3064917-67-2
物质唯一标识(Unique Ingredient Identifier)2XJ94NG3WX
分子式
国际化合物标识(International Chemical Identifier,InChI)
SMILES
分子结构式
欧洲化学品管理局注册号(ECHA)
成分类型 / INGREDIENT SUBSTANCE
关联数据
  • 药品国际非专利名称数据库
扩展资源
©2006-2026 Drugfuture->FDA Global Substance Registration System